Unit
Dermatologie | Venerologie | Allergologie
DERMA · Dept. IV
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
Wagner N, Utikal J, Umansky V, Garbe C, Schadendorf D, Holland-Letz T, Herpel E, Sucker A, Lichtenberger R, Funder A, Kehrel C, Kemper C, Schuermans V, Tarnanidis K, Reith M, Gries M, Weide B, Gebhardt C. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies. J Immunother Cancer 2019; 7:343.
Dec 5, 2019Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
Dec 5, 2019J Immunother Cancer 2019; 7:343
Wagner Nikolaus, Utikal Jochen, Umansky Viktor, Garbe Claus, Schadendorf Dirk, Holland-Letz Tim, Herpel Esther, Sucker Antje, Lichtenberger Ramtin, Funder Anne, Kehrel Coretta, Kemper Charlotte, Schuermans Valerie, Tarnanidis Kathrin, Reith Maike, Gries Mirko, Weide Benjamin, Gebhardt Christoffer
Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
Gil Cruz C, Jahns R, Wyss M, Mooser C, Lambrecht B, Maeder M, Rickli H, Flatz L, Eriksson U, Geuking M, McCoy K, Boivin-Jahns V, Slack E, Arnoldini M, Pérez Shibayama C, De Martin A, Ronchi F, Van der Borght K, Niederer R, Onder L, Lütge M, Novkovic M, Nindl V, Ramos G, Ludewig B. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science 2019; 366:881-886.
Nov 15, 2019Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
Nov 15, 2019Science 2019; 366:881-886
Gil Cruz Cristina, Jahns Roland, Wyss Madeleine, Mooser Catherine, Lambrecht Bart N, Maeder Micha, Rickli Hans, Flatz Lukas, Eriksson Urs, Geuking Markus B, McCoy Kathy D, Boivin-Jahns Valérie, Slack Emma M C, Arnoldini Markus, Pérez Shibayama Christian Ivan, De Martin Angelina, Ronchi Francesca, Van der Borght Katrien, Niederer Rebekka, Onder Lucas, Lütge Mechthild, Novkovic Mario, Nindl Veronika, Ramos Gustavo, Ludewig Burkhard
Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry
Cazzaniga S, Kolios A, Laffitte E, Maul J, Mainetti C, Naldi L, Navarini A, Rustenbach S, Simon D, Sorbe C, Streit M, Itin P, Heidemeyer K, Anzengruber F, Augustin M, Boehncke W, Borradori L, Conrad C, Cozzio A, Djamei V, French L, Gilliet M, Häusermann P, Yawalkar N. Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry. J Eur Acad Dermatol Venereol 2019; 33:2313-2318.
Oct 28, 2019Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry
Oct 28, 2019J Eur Acad Dermatol Venereol 2019; 33:2313-2318
Cazzaniga S, Kolios A G A, Laffitte E, Maul J-T, Mainetti C, Naldi L, Navarini A A, Rustenbach S J, Simon D, Sorbe C, Streit M, Itin P, Heidemeyer K, Anzengruber F, Augustin M, Boehncke W H, Borradori L, Conrad C, Cozzio Antonio, Djamei V, French L E, Gilliet M, Häusermann P, Yawalkar N
Immune-Related Adverse Events of Immune Checkpoint Inhibitors-From a Clinical to Pathophysiological View-In Reply
Berner F, Bomze D, Flatz L. Immune-Related Adverse Events of Immune Checkpoint Inhibitors-From a Clinical to Pathophysiological View-In Reply. JAMA Oncol 2019
Oct 3, 2019Immune-Related Adverse Events of Immune Checkpoint Inhibitors-From a Clinical to Pathophysiological View-In Reply
Oct 3, 2019JAMA Oncol 2019
Berner Fiamma, Bomze David, Flatz Lukas
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors
Hasan Ali O, Sadik C, Zillikens D, Schmidt E, Jochum W, Mani B, Cozzio A, Braun A, Emtenani S, Hammers C, Abdou M, Diem S, Fässler M, Berner F, Ring S, Bomze D, Flatz L. BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors. J Am Acad Dermatol 2019; 82:854-861.
Aug 23, 2019BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors
Aug 23, 2019J Am Acad Dermatol 2019; 82:854-861
Hasan Ali Omar, Sadik Christian D, Zillikens Detlef, Schmidt Enno, Jochum Wolfram, Mani Bernhard, Cozzio Antonio, Braun Anne, Emtenani Shirin, Hammers Christoph, Abdou Marie-Therese, Diem Stefan, Fässler Mirjam, Berner Fiamma, Ring Sandra S, Bomze David, Flatz Lukas
Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden
Bomze D, Hasan Ali O, Bate A, Flatz L. Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden. JAMA Oncol 2019
Aug 22, 2019Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden
Aug 22, 2019JAMA Oncol 2019
Bomze David, Hasan Ali Omar, Bate Andrew, Flatz Lukas
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
Bochem J, Weide B, Pawelec G, Garbe C, Meier F, Terheyden P, Uslu U, Wagner N, Eigentler T, Soffel D, Spreuer J, Amaral T, Zelba H, Wistuba-Hamprecht K. Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade. PloS one 2019; 14:e0221301.
Aug 16, 2019Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
Aug 16, 2019PloS one 2019; 14:e0221301
Bochem Jonas, Weide Benjamin, Pawelec Graham, Garbe Claus, Meier Friedegund, Terheyden Patrick, Uslu Ugur, Wagner Nikolaus, Eigentler Thomas, Soffel Daniel, Spreuer Janine, Amaral Teresa, Zelba Henning, Wistuba-Hamprecht Kilian
[Warning symptoms skin: cutaneous manifestation of drug allergy]
Saulite I, Hötzenecker W, Cozzio A. [Warning symptoms skin: cutaneous manifestation of drug allergy]. Ther Umsch 2019; 75:43-48.
Jul 1, 2019[Warning symptoms skin: cutaneous manifestation of drug allergy]
Jul 1, 2019Ther Umsch 2019; 75:43-48
Saulite Ieva, Hötzenecker Wolfram, Cozzio Antonio
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
Berner F, Hartmann F, Cheng H, Hönger G, Recher M, Goldman J, Cozzio A, Früh M, Neefjes J, Driessen C, Ludewig B, Hegazy A, Jochum W, Speiser D, Zippelius A, Läubli H, Bomze D, Diem S, Ali O, Fässler M, Ring S, Niederer R, Ackermann C, Baumgaertner P, Pikor N, Cruz C, van de Veen W, Akdis M, Nikolaev S, Flatz L. Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer. JAMA Oncol 2019; 5:1043-1047.
Jul 1, 2019Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer
Jul 1, 2019JAMA Oncol 2019; 5:1043-1047
Berner Fiamma, Hartmann Fabienne, Cheng Hung-Wei, Hönger Gideon, Recher Mike, Goldman Jonathan, Cozzio Antonio, Früh Martin, Neefjes Jacques, Driessen Christoph, Ludewig Burkhard, Hegazy Ahmed N, Jochum Wolfram, Speiser Daniel E, Zippelius Alfred, Läubli Heinz, Bomze David, Diem Stefan, Ali Omar Hasan, Fässler Mirjam, Ring Sandra, Niederer Rebekka, Ackermann Christoph J, Baumgaertner Petra, Pikor Natalia, Cruz Cristina Gil, van de Veen Willem, Akdis Mübeccel, Nikolaev Sergey, Flatz Lukas
Health-related Quality of Life in Cutaneous Lymphomas: Past, Present and Future
Jonak C, Porkert S, Oerlemans S, Papadavid E, Molloy K, Lehner-Baumgartner E, Cozzio A, Efficace F, Scarisbrick J. Health-related Quality of Life in Cutaneous Lymphomas: Past, Present and Future. Acta Derm Venereol 2019; 99:640-646.
Jun 1, 2019Health-related Quality of Life in Cutaneous Lymphomas: Past, Present and Future
Jun 1, 2019Acta Derm Venereol 2019; 99:640-646
Jonak Constanze, Porkert Stefanie, Oerlemans Simone, Papadavid Evangelia, Molloy Kevin, Lehner-Baumgartner Eva, Cozzio Antonio, Efficace Fabio, Scarisbrick Julia
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
Diem S, Risch M, Recher M, Risch L, Dummer R, Levesque M, Mangana J, Hillmann D, Niederer R, Berner F, Ali O, Bomze D, Fässler M, Flatz L. Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. J Immunother 2019; 42:89-93.
Apr 1, 2019Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
Apr 1, 2019J Immunother 2019; 42:89-93
Diem Stefan, Risch Martin, Recher Mike, Risch Lorenz, Dummer Reinhard, Levesque Mitchell P, Mangana Joanna, Hillmann Dorothea, Niederer Rebekka, Berner Fiamma, Ali Omar Hasan, Bomze David, Fässler Mirjam, Flatz Lukas
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Fässler M, Jörger M, Recher M, Risch L, Güsewell S, Risch M, Speiser D, Ludewig B, Levesque M, Dummer R, Siano M, Krolik M, Diem S, Mangana J, Hasan Ali O, Berner F, Bomze D, Ring S, Niederer R, Gil Cruz C, Pérez Shibayama C, Flatz L. Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. J Immunother Cancer 2019; 7:50.
Feb 20, 2019Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Feb 20, 2019J Immunother Cancer 2019; 7:50
Fässler Mirjam, Jörger Markus, Recher Mike, Risch Lorenz, Güsewell Sabine, Risch Martin, Speiser Daniel E, Ludewig Burkhard, Levesque Mitchell P, Dummer Reinhard, Siano Marco, Krolik Michal, Diem Stefan, Mangana Joanna, Hasan Ali Omar, Berner Fiamma, Bomze David, Ring Sandra, Niederer Rebekka, Gil Cruz Cristina, Pérez Shibayama Christian Ivan, Flatz Lukas
A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer
Trefny M, Savic S, Jermann P, Alborelli I, Schaub S, Stenner F, Früh M, Trajanoski Z, Flatz L, Mertz K, Zippelius A, Geier F, Thommen D, Rothschild S, Uhlenbrock F, Rieder D, Kasenda B, Stanczak M, Berner F, Kashyap A, Kaiser M, Herzig P, Poechtrager S, Läubli H. A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer. Clin Cancer Res 2019; 25:3026-3034.
Feb 14, 2019A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer
Feb 14, 2019Clin Cancer Res 2019; 25:3026-3034
Trefny Marcel P, Savic Spasenija, Jermann Philip, Alborelli Ilaria, Schaub Stefan, Stenner Frank, Früh Martin, Trajanoski Zlatko, Flatz Lukas, Mertz Kirsten D, Zippelius Alfred, Geier Florian, Thommen Daniela S, Rothschild Sacha I, Uhlenbrock Franziska, Rieder Dietmar, Kasenda Benjamin, Stanczak Michal A, Berner Fiamma, Kashyap Abhishek S, Kaiser Monika, Herzig Petra, Poechtrager Severin, Läubli Heinz
A Rare Case of Localized Argyria on the Face
Isak V, Beerli T, Cozzio A, Flatz L. A Rare Case of Localized Argyria on the Face. Case Rep Dermatol 2019; 11:23-27.
Feb 13, 2019A Rare Case of Localized Argyria on the Face
Feb 13, 2019Case Rep Dermatol 2019; 11:23-27
Isak Verena, Beerli Tobias, Cozzio Antonio, Flatz Lukas
Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice
Maul J, Laffitte E, Streit M, Rustenbach S, Conrad C, Borradori L, Gilliet M, Cozzio A, Itin P, Häusermann P, French L, Radtke M, Mainetti C, Yawalkar N, Körber A, Navarini A, Sommer R, Anzengruber F, Sorbe C, Mrowietz U, Drach M, Blome C, Boehncke W, Thaci D, Reich K, von Kiedrowski R, Augustin M. Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice. J Eur Acad Dermatol Venereol 2019; 33:700-708.
Jan 15, 2019Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice
Jan 15, 2019J Eur Acad Dermatol Venereol 2019; 33:700-708
Maul J-T, Laffitte E, Streit M, Rustenbach S, Conrad C, Borradori L, Gilliet M, Cozzio Antonio, Itin P, Häusermann P, French L E, Radtke M A, Mainetti C, Yawalkar N, Körber A, Navarini A A, Sommer R, Anzengruber F, Sorbe C, Mrowietz U, Drach M, Blome C, Boehncke W-H, Thaci D, Reich K, von Kiedrowski R, Augustin M
Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
Hartwig T, Schlapbach C, Conrad C, Flatz L, Dummer R, Navarini A, Cheng P, Yawalkar N, Schreiner B, Zwicky P, Becher B. Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation. Cell Rep 2018; 25:3564-3572.e4.
Dec 26, 2018Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation
Dec 26, 2018Cell Rep 2018; 25:3564-3572.e4
Hartwig Tom, Schlapbach Christoph, Conrad Curdin, Flatz Lukas, Dummer Reinhard, Navarini Alexander, Cheng Phil, Yawalkar Nikhil, Schreiner Bettina, Zwicky Pascale, Becher Burkhard
Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors
Hasan Ali O, Lenz T, Driessen C, Früh M, Jörger M, Cozzio A, Diem S, Fässler M, Bomze D, Berner F, Flatz L. Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors. Eur J Cancer 2018; 107:8-14.
Dec 7, 2018Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors
Dec 7, 2018Eur J Cancer 2018; 107:8-14
Hasan Ali Omar, Lenz Tobias L, Driessen Christoph, Früh Martin, Jörger Markus, Cozzio Antonio, Diem Stefan, Fässler Mirjam, Bomze David, Berner Fiamma, Flatz Lukas
European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis
Oosterhaven J, Mahler V, Rustemeyer T, Sadowska-Przytocka A, Sánchez-Pérez J, Simon D, Valiukevičienė S, Weisshaar E, Schuttelaar M, Kręcisz B, John S, Giménez-Arnau A, Uter W, Aberer W, Armario-Hita J, Ballmer-Weber B, Bauer A, Czarnecka-Operacz M, Elsner P, García-Gavín J, ESSCA Working Group. European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis. Contact Derm 2018
Dec 5, 2018European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis
Dec 5, 2018Contact Derm 2018
Oosterhaven Jart A F, Mahler Vera, Rustemeyer Thomas, Sadowska-Przytocka Anna, Sánchez-Pérez Javier, Simon Dagmar, Valiukevičienė Skaidra, Weisshaar Elke, Schuttelaar Marie L A, Kręcisz Beata, John Swen M, Giménez-Arnau Ana M, Uter Wolfgang, Aberer Werner, Armario-Hita José C, Ballmer-Weber Barbara, Bauer Andrea, Czarnecka-Operacz Magdalena, Elsner Peter, García-Gavín Juan, ESSCA Working Group
The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients
Yoo J, Busschots A, Hauben E, Bervoets A, Woei-A-Jin F, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Ranki A, Vakeva L, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen M, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Arumainathan A, Azurdia R, Klemke C, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Bur C, Folkes A, Benstead K, Twigger R, Rieger K, Brown R, Sanches J, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco F, Querfeld C, Willemze R, Latzka J, Scarisbrick J, Whittaker S, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Child F, Guenova E, Quaglino P, Prince H, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Koletsa T, Jonak C, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Pham-Ledard A, Beylot-Barry M, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio A, Dummer R, Pimpinelli N, Grandi V, Trautinger F. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol 2018; 181:350-357.
Nov 25, 2018The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients
Nov 25, 2018Br J Dermatol 2018; 181:350-357
Yoo J, Busschots A-M, Hauben E, Bervoets A, Woei-A-Jin F J S H, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Ranki A, Vakeva L, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen M-D, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Arumainathan A, Azurdia R, Klemke C-D, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Bur C, Folkes A, Benstead K, Twigger R, Rieger K, Brown R, Sanches J A, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco F M, Querfeld C, Willemze R, Latzka J, Scarisbrick J J, Whittaker S, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Child F, Guenova E, Quaglino P, Prince H M, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Koletsa T, Jonak C, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Pham-Ledard A, Beylot-Barry M, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio Antonio, Dummer R, Pimpinelli N, Grandi V, Trautinger F
Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment
Diem S, Früh M, Güsewell S, Schmid S, Ackermann C, Roux G, Berner F, Niederer R, Siano M, Ali O, Fässler M, Flatz L. Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment. Cancer Manag Res 2018; 10:5537-5544.
Nov 8, 2018Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment
Nov 8, 2018Cancer Manag Res 2018; 10:5537-5544
Diem Stefan, Früh Martin, Güsewell Sabine, Schmid Sabine, Ackermann Christoph Jakob, Roux Guillaume-Alexandre, Berner Fiamma, Niederer Rebekka, Siano Marco, Ali Omar Hasan, Fässler Mirjam, Flatz Lukas